PIGMENTATION DISORDERS TREATMENT MARKET ANALYSIS

Pigmentation Disorders Treatment Market, By Disorder Type (Melasma, Vitiligo, Albinism, Post-Inflammatory Hyperpigmentation (PIH), and Others), By Drug Type (Corticosteroids, Calcineurin Inhibitors, Janus kinase inhibitor, Melanin Synthesis Inhibitor, and Others), By Route of Administration (Oral, Topical, and Other), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Apr 2024
Code : CMI5421
Pages :172
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Pigmentation Disorders Treatment Market Regional Insights

To learn more about this report, request sample copy

North America remains the dominant region in the global pigmentation disorders treatment market and is estimated to hold 41.7% of the market share in 2024 due to the increasing prevalence of pigmentation disorders and growing geriatric population in the region. According to the U.S. Census Bureau (2022 report), over 56 million adults ages 65 and older live in the U.S., accounting for about 16.9% of the nation's population. By 2030, it is projected that there will be around 73.1 million older adults. This in turn is driving the market growth.

The Asia Pacific region has emerged as the fastest growing market due to the high prevalence of pigmentation disorders and rise in geriatric population in Asia Pacific region. As, pigmentation disorders more prevalent in the geriatric population. Asia Pacific is a home to some of the world's oldest population, those ages 65 and above. As per United Nations Economic and Social Commission for Asia and the Pacific (July 2022 report), there are 630 million people aged 60 years or over, representing 60 per cent of the world's older persons. By 2050, their number is projected to increase to 1.3 billion.